At SmartBio Analytics, we are proud to announce our collaboration with Rey Juan Carlos University (URJC) as part of the Master’s Degree in Proteomics and Metabolomics Applied to Clinical Practice and Personalized Medicine.
This collaboration reflects our commitment to bridging academia and industry while contributing to the education of future professionals in bioanalysis, proteomics, metabolomics, pharmaceutical sciences and precision medicine.
Through this initiative, our team will share real-world experience from a GLP-certified bioanalytical laboratory, helping students understand how advanced analytical technologies support modern drug development and clinical research.
About the Master’s Programme
The Master’s Degree in Proteomics and Metabolomics Applied to Clinical Practice and Personalized Medicine is an advanced postgraduate programme designed to provide students with both theoretical knowledge and practical skills in the application of proteomics and metabolomics to biomedical research and healthcare.
The programme covers topics including:
- Proteomics and metabolomics technologies
- Mass spectrometry and analytical instrumentation
- Biomarker discovery and validation
- Precision and personalized medicine
- Clinical applications of omics sciences
- Translational biomedical research
- Experimental design and data interpretation
The programme combines academic excellence with practical laboratory training, preparing graduates for careers in academia, biotechnology, pharmaceutical companies, hospitals and CROs.
Bringing real-world bioanalysis into the classroom
As part of this collaboration, Adán Alpízar, PhD, Scientific Director of SmartBio Analytics, and Rafa Terán, General Manager, will join the teaching staff to provide students with an industry perspective on modern bioanalysis.
Our lectures will focus on the practical challenges faced by pharmaceutical and biotechnology companies, covering topics such as:
- Bioanalytical method development
- Bioanalytical method validation
- LC-MS/MS workflows
- Pharmacokinetic (PK) and toxicokinetic (TK) studies
- Biomarker quantification
- Regulatory expectations for bioanalysis
- Good Laboratory Practice (GLP)
- Translating analytical science into drug development
By sharing real case studies and industry experience, students will gain insight into how analytical methods are developed, validated and applied to support preclinical and clinical studies.
Learn more about our Bioanalytical Method Development and Validation Services
Why LC-MS/MS bioanalysis matters
Bioanalysis plays a critical role throughout the pharmaceutical development process.
Whether supporting small molecules, peptides, proteins, oligonucleotides or biomarkers, robust analytical methods are essential to generate reliable pharmacokinetic and pharmacodynamic data.
At SmartBio Analytics, we specialise in LC-MS/MS bioanalysis, providing high-quality analytical support for:
- Bioanalytical method development
- Method transfer
- Method qualification
- Method validation
- Sample analysis
- PK/TK studies
- Biomarker quantification
- Preclinical and clinical studies
Our laboratory supports pharmaceutical companies, biotechnology companies, hospitals, research institutions and CROs throughout every stage of drug development.
Learn more about our LC-MS/MS Bioanalysis Services
Internship opportunities for Master’s students
Beyond classroom teaching, selected students will have the opportunity to complete internships at SmartBio Analytics.
Working alongside experienced scientists, students will gain hands-on experience in a regulated bioanalytical laboratory, participating in activities such as:
- Sample preparation
- LC-MS/MS analysis
- Method development
- Instrument operation
- Data review
- Quality systems
- Scientific problem-solving
These internships provide valuable exposure to the daily operation of a contract research organization (CRO) and help students prepare for careers in the pharmaceutical and biotechnology industries.
Connecting academia and industry
Innovation in life sciences depends on strong collaboration between universities, research centres and industry.
At SmartBio Analytics, we strongly believe that scientific education should be closely connected to the realities of pharmaceutical development.
By participating in this Master’s programme, we hope to inspire future scientists while helping students understand how advanced bioanalytical technologies contribute to the development of safer and more effective medicines.
We would like to thank María Posada Ayala and the entire team at Rey Juan Carlos University for inviting SmartBio Analytics to become part of this exciting initiative.
About SmartBio Analytics
SmartBio Analytics is a GLP-certified bioanalytical CRO based in Madrid, Spain, specialising in LC-MS/MS bioanalysis for pharmaceutical, biotechnology and biomedical research.
Our expertise includes:
- LC-MS/MS bioanalysis
- Bioanalytical method development
- Bioanalytical method validation
- Pharmacokinetic studies (PK)
- Toxicokinetic studies (TK)
- Biomarker analysis
- Small molecules
- Peptides
- Proteins
- Oligonucleotides
- Clinical and preclinical bioanalysis
Explore all our services
Looking for a trusted bioanalytical partner?
If your organisation requires support with LC-MS/MS bioanalysis, bioanalytical method development, method validation, pharmacokinetic studies or biomarker analysis, our team would be pleased to help.